title: Cell-based drug-delivery platforms.
abstract: Cell systems have recently emerged as biological drug carriers, as an interesting alternative to other systems such as micro- and nano-particles. Different cells, such as carrier erythrocytes, bacterial ghosts and genetically engineered stem and dendritic cells have been used. They provide sustained release and specific delivery of drugs, enzymatic systems and genetic material to certain organs and tissues. Cell systems have potential applications for the treatment of cancer, HIV, intracellular infections, cardiovascular diseases, Parkinson's disease or in gene therapy. Carrier erythrocytes containing enzymes such us L-asparaginase, or drugs such as corticosteroids have been successfully used in humans. Bacterial ghosts have been widely used in the field of vaccines and also with drugs such as doxorubicin. Genetically engineered stem cells have been tested for cancer treatment and dendritic cells for immunotherapeutic vaccines. Although further research and more clinical trials are necessary, cell-based platforms are a promising strategy for drug delivery.
authors: Department of Pharmacy & Pharmaceutical Technology, Faculty of Pharmacy, University of Salamanca, Spain.
authors: Carmen
authors: C
authors: Gutiérrez Millán
authors: Clara Isabel
authors: CI
authors: Colino Gandarillas
authors: María Luisa
authors: ML
authors: Sayalero Marinero
authors: José M
authors: JM
authors: Lanao
mesh_terms: D003713:Dendritic Cells / Q000276:immunology; D016503:Drug Delivery Systems; D004912:Erythrocytes / Q000502:physiology; D006801:Humans; D007167:Immunotherapy; D013234:Stem Cells / Q000502:physiology